Sleeping Aids Market - Global Industry Size, Share, Trends, Opportunity, and Forecast,egmented By Product Type, By Sleep Disorder, By Distribution Channel, By Region and Competition, 2020-2030F

Description

The Global Sleeping Aids Market, valued at USD 66.52 Billion in 2024, is projected to experience a CAGR of 6.45% to reach USD 96.79 Billion by 2030. Sleeping aids encompass a broad spectrum of pharmaceutical and non-pharmaceutical products and therapies designed to enhance sleep quality and address various sleep disorders, including medications, supplements, and specialized devices. The market's expansion is primarily driven by the escalating global prevalence of sleep disorders and a growing awareness of sleep health. An aging global population, increasing stress levels, and changing lifestyles contribute significantly to these disorders.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 66.52 Billion
Market Size 2030	USD 96.79 Billion
CAGR 2025-2030	6.45%
Fastest Growing Segment	Hospital Pharmacies
Largest Market	North America

Key Market Drivers

The increased prevalence of sleep disorders significantly drives the global sleeping aids market. As populations contend with conditions such as insomnia and sleep apnea, demand for effective diagnostic tools and therapeutic interventions grows. For instance, according to a survey commissioned by the American Academy of Sleep Medicine, in June 2024, 12% of Americans reported a diagnosis of chronic insomnia, highlighting a substantial segment of the population seeking relief.

Key Market Challenges

A significant challenge impeding market expansion in the Global Sleeping Aids Market is the ongoing concern regarding the potential side effects and dependency risks associated with certain prescription sleep medications. This apprehension directly influences consumer behavior, often leading individuals to prefer non-pharmacological alternatives or to discontinue treatment. This reluctance to use or continue prescription sleep aids directly hampers market growth in specific product segments. For instance, according to the American Academy of Sleep Medicine's 2024 Sleep in America poll, 38% of adults who experience sleep difficulties reported actively avoiding prescription sleep medication due to worries about potential side effects or addiction. This consumer shift limits sustained market expansion for pharmaceutical solutions, as a substantial portion of the target demographic opts for perceived safer options. The market consequently experiences constrained growth in segments reliant on prescription sales, impacting overall adoption rates and the potential for greater market penetration.

Key Market Trends

The increasing consumer preference for natural and herbal sleep aids is significantly reshaping the global sleeping aids market. Consumers are increasingly seeking alternatives to traditional pharmaceutical options, driven by concerns about potential side effects and dependency risks associated with prescription medications. This shift is expanding the market beyond conventional offerings toward botanical and supplement-based solutions. According to the Council for Responsible Nutrition 2024 Consumer Survey, published in October 2024, magnesium usage among supplement users rose from 19% in 2023 to 23% in 2024, while ashwagandha use increased from 2% in 2020 to 8% in 2024, reflecting growing interest in ingredients often found in natural sleep aids. This rising demand encourages innovation and product development in the natural segment. For instance, in May 2024, Natrol, a prominent melatonin brand, introduced Time Release Melatonin gummies, designed for dual-action delivery to assist with both falling and staying asleep, catering to this evolving consumer preference.

Key Market Players

AstraZeneca Plc
BMC Medical Co., Ltd.
Cadwell Industries, Inc
Compumedics Limited
Drive DeVilbiss Healthcare Inc
Eisai Co. Ltd.
Fisher & Paykel Healthcare Limited
GlaxoSmithKline Plc
Idorsia Pharmaceuticals Ltd
Koninklijke Philips N.V

Report Scope:

In this report, the Global Sleeping Aids Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Sleeping Aids Market, By Product Type:

Mattresses & Pillows
Medications
Sleep Apnea Devices
Others

Sleeping Aids Market, By Sleep Disorder:

Insomnia
Narcolepsy
Restless Leg Syndrome
Sleep Apnea
Others

Sleeping Aids Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
E-commerce
Drug Stores
Others

Sleeping Aids Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Sleeping Aids Market.

Available Customizations:

Global Sleeping Aids Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Sleeping Aids Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Product Type (Mattresses & Pillows, Medications, Sleep Apnea Devices, Others)
- 5.2.2. By Sleep Disorder (Insomnia, Narcolepsy, Restless Leg Syndrome, Sleep Apnea, Others)
- 5.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-commerce, Drug Stores, Others)
- 5.2.4. By Region
- 5.2.5. By Company (2024)
5.3. Market Map

6. North America Sleeping Aids Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product Type
- 6.2.2. By Sleep Disorder
- 6.2.3. By Distribution Channel
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Sleeping Aids Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Product Type
    - 6.3.1.2.2. By Sleep Disorder
    - 6.3.1.2.3. By Distribution Channel
- 6.3.2. Canada Sleeping Aids Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Product Type
    - 6.3.2.2.2. By Sleep Disorder
    - 6.3.2.2.3. By Distribution Channel
- 6.3.3. Mexico Sleeping Aids Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Product Type
    - 6.3.3.2.2. By Sleep Disorder
    - 6.3.3.2.3. By Distribution Channel

7. Europe Sleeping Aids Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product Type
- 7.2.2. By Sleep Disorder
- 7.2.3. By Distribution Channel
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Sleeping Aids Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product Type
    - 7.3.1.2.2. By Sleep Disorder
    - 7.3.1.2.3. By Distribution Channel
- 7.3.2. France Sleeping Aids Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product Type
    - 7.3.2.2.2. By Sleep Disorder
    - 7.3.2.2.3. By Distribution Channel
- 7.3.3. United Kingdom Sleeping Aids Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Product Type
    - 7.3.3.2.2. By Sleep Disorder
    - 7.3.3.2.3. By Distribution Channel
- 7.3.4. Italy Sleeping Aids Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Product Type
    - 7.3.4.2.2. By Sleep Disorder
    - 7.3.4.2.3. By Distribution Channel
- 7.3.5. Spain Sleeping Aids Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Product Type
    - 7.3.5.2.2. By Sleep Disorder
    - 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Sleeping Aids Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product Type
- 8.2.2. By Sleep Disorder
- 8.2.3. By Distribution Channel
- 8.2.4. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Sleeping Aids Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product Type
    - 8.3.1.2.2. By Sleep Disorder
    - 8.3.1.2.3. By Distribution Channel
- 8.3.2. India Sleeping Aids Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product Type
    - 8.3.2.2.2. By Sleep Disorder
    - 8.3.2.2.3. By Distribution Channel
- 8.3.3. Japan Sleeping Aids Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product Type
    - 8.3.3.2.2. By Sleep Disorder
    - 8.3.3.2.3. By Distribution Channel
- 8.3.4. South Korea Sleeping Aids Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Product Type
    - 8.3.4.2.2. By Sleep Disorder
    - 8.3.4.2.3. By Distribution Channel
- 8.3.5. Australia Sleeping Aids Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Product Type
    - 8.3.5.2.2. By Sleep Disorder
    - 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Sleeping Aids Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product Type
- 9.2.2. By Sleep Disorder
- 9.2.3. By Distribution Channel
- 9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Sleeping Aids Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product Type
    - 9.3.1.2.2. By Sleep Disorder
    - 9.3.1.2.3. By Distribution Channel
- 9.3.2. UAE Sleeping Aids Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product Type
    - 9.3.2.2.2. By Sleep Disorder
    - 9.3.2.2.3. By Distribution Channel
- 9.3.3. South Africa Sleeping Aids Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product Type
    - 9.3.3.2.2. By Sleep Disorder
    - 9.3.3.2.3. By Distribution Channel

10. South America Sleeping Aids Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product Type
- 10.2.2. By Sleep Disorder
- 10.2.3. By Distribution Channel
- 10.2.4. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Sleeping Aids Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Product Type
    - 10.3.1.2.2. By Sleep Disorder
    - 10.3.1.2.3. By Distribution Channel
- 10.3.2. Colombia Sleeping Aids Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Product Type
    - 10.3.2.2.2. By Sleep Disorder
    - 10.3.2.2.3. By Distribution Channel
- 10.3.3. Argentina Sleeping Aids Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Product Type
    - 10.3.3.2.2. By Sleep Disorder
    - 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Sleeping Aids Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. AstraZeneca Plc
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. BMC Medical Co., Ltd.
15.3. Cadwell Industries, Inc
15.4. Compumedics Limited
15.5. Drive DeVilbiss Healthcare Inc
15.6. Eisai Co. Ltd.
15.7. Fisher & Paykel Healthcare Limited
15.8. GlaxoSmithKline Plc
15.9. Idorsia Pharmaceuticals Ltd
15.10. Koninklijke Philips N.V